Concepedia

Author

Pellegrino Musto

Istituti di Ricovero e Cura a Carattere ScientificoORCID

Also Known As

Angelo Michele Carella, Carella, Angelo Michele, Daniela Chiusole, Emanuela Resta, Musto, Pellegrino, N Karanjia, Nicola Sgherza, P MUSTO, P Musto, P. MUSTO

956

Publications

29K

Citations

81

H-Index

169

Concepts

All Affiliations

Istituti di Ricovero e Cura a Carattere ScientificoCentro di Riferimento Oncologico della BasilicataCasa Sollievo della SofferenzaUniversity of TurinSapienza University of Rome
PM

About

Pellegrino Musto is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in medicine, hematology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

45

122

7.2K

2

Health Sciences

26

47

3.5K

3

Engineering

2

2

30

4

Education

1

1

26

5

Nursing

1

1

21

Pellegrino Musto

×

296

Publications

23.6K

Citations

77

H-Index

YearCitations

Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

Antonio Palumbo, Hervé Avet‐Loiseau, Stefania Oliva,

Journal of Clinical Oncology

2015

2.1K

<i>BRAF</i> Mutations in Hairy-Cell Leukemia

Enrico Tiacci, Gianluca Schiavoni, Antony B. Holmes,

New England Journal of Medicine

2011

1K

Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial

Antonio Palumbo, Tommaso Caravita, Emanuela Merla,

The Lancet

2006

808

Cardiovascular Events and Intensity of Treatment in Polycythemia Vera

Roberto Marchioli, Guido Finazzi, Giorgina Specchia,

New England Journal of Medicine

2012

791

Autologous Transplantation and Maintenance Therapy in Multiple Myeloma

Antonio Palumbo, Federica Cavallo, Francesca Gay,

New England Journal of Medicine

2014

774

Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report

Antonio Palumbo, Sara Bringhen, María‐Victoria Mateos,

Blood

2015

739

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study

Francesco Passamonti, Chiara Cattaneo, Luca Arcaini,

The Lancet Haematology

2020

551

Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: A Randomized Controlled Trial

Antonio Palumbo, Davide Rossi, Maide Cavalli,

Journal of Clinical Oncology

2010

424

European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications

Evangelos Terpos, Martina Kleber, Monika Engelhardt,

Haematologica

2015

391

Efficacy and safety of once-weekly bortezomib in multiple myeloma patients

Alessandra Larocca, Davide Rossi, Maide Cavalli,

Blood

2010

379

Page 1